Sequencing Segment tDrive Molecular Biology Enzymes, Kits, and Reagents Market
According tour new research study on “Molecular Biology Enzymes, Kits & Reagents Market Forecast t2028 – COVID-19 Impact and Global Analysis – by Product, Application, and End User,” the market is expected treach US$ 41,104.71 million by 2028 from US$ 10,987.17 million in 2020; it is estimated tgrow at a CAGR of 17.8% from 2021 t2028. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the market is attributed ta few key driving factors such as healthy funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases. However, the dearth of skilled professionals hinders the market growth.
Biological enzymes play a prominent role in encouraging chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These reagents are alsutilized during various processes such as polymerase chain reaction (PCR), DNA sequencing, and cell analysis. Rising investments in the life science industry are prominently driving the growth of the molecular biology enzymes, kits, and reagents market.
Based on application, the molecular biology enzymes, kits, and reagents market is segmented intepigenetics, sequencing, synthetic biology, polymerase chain reaction, and other. In 2020, the sequencing segment held the largest share of the market. However, the polymerase chain reaction segment is estimated tregister the highest CAGR of 19.3% during the forecast period.
The molecular biology enzymes, kits, and reagents market is witnessing substantial growth amid COVID-19 pandemic. The majority of the healthcare research organizations, market players, and academic centers are actively engaged in the research and development activities tdevelop new vaccines and therapeutic platforms for novel coronavirus that causes COVID-19. This extensive rise in research and development activities is expected tboost the demand for molecular biology kits and reagents, which, in turn, would drive the growth of the molecular biology enzymes, kits, and reagents market in coming years.
THERMFISHER SCIENTIFIC INC; Illumina, Inc.; Qiagen; Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Merck KGAA; Jena Bioscience GmbH; Bioline Technologies; Promega Corporation; and Rockland Immunochemicals Inc are among the leading companies operating in the molecular biology enzymes, kits, and reagents market.
The report segments molecular biology enzymes, kits, and reagents market as follows:
By Product
- Enzymes
- Polymerases
- Ligases
- Reverse Transcriptases
- Phosphatases
- Proteases and Proteinases
- Restriction Endonuclease
- Other
- Kits and Reagents
By Application
- Epigenetics
- Sequencing
- Synthetic Biology
- Polymerase Chain Reaction
- Other
By End User
- Biotechnological and Pharmaceutical Companies
- Hospitals and Diagnostic Centres
- Academic and Research Institutes
By Geography- North America
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
- Middle East & Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Contact UsContact Person: Sameer JoshiPhone: +1-646-491-9876Email Id: sales@reportsweb.com
